Cargando…
Iron therapy as a novel treatment of scleroderma‐related pulmonary hypertension: A case report and literature review
Pulmonary arterial hypertension (PAH) is the leading cause of death in patients with systemic sclerosis (SSc), with a 3‐year mortality of 40%–50% despite optimal therapy. Treatment mirrors that of idiopathic PAH and is often ineffective. This is a case report of a patient with SSc evaluated for prog...
Autores principales: | Neumann, Melissa, Wong, Karen A., Lazo, Kevin, Stover, Diane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767940/ https://www.ncbi.nlm.nih.gov/pubmed/35079404 http://dx.doi.org/10.1002/rcr2.904 |
Ejemplares similares
-
The frequency of pulmonary hypertension in juvenile scleroderma
por: Adrovic, Amra, et al.
Publicado: (2014) -
Sarcoidosis presenting as hiccups
por: Neumann, Melissa, et al.
Publicado: (2020) -
Pulmonary arterial hypertension in scleroderma: care gaps in screening
por: Pope, Janet E.
Publicado: (2017) -
Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension
por: Sugino, Keishi, et al.
Publicado: (2018) -
Borderline pulmonary pressures in scleroderma - a ‘pre-pulmonary arterial hypertension’ condition?
por: Kovacs, Gabor, et al.
Publicado: (2015)